drugset / Trial / NCT02378974

Evaluation of the Safety and Potential Therapeutic Effects of Cordstem-ST in Patients With Cerebral Infarction

NCT02378974 ↗

Phase 1/2 Completed 18 enrolled CHABiotech CO., Ltd
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of the study is to evaluate the safety and the potential therapeutic effects per dose of Cordstem-ST Intravenous Transplantation in Cerebral Infarction subjects

Timeline

Start
2015-02
Primary completion
2017-04
Completion
2017-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Cordstem-ST Cell therapy — Intravenous

Indications